July 13, 2013 08:30 ET | SOURCE: Regen BioPharma, Inc.
Bio-Matrix Scientific Group Provides Update on Its Regen BioPharma’s HemaXellerate I(TM) Clinical Program
June 07, 2013 08:30 ET | SOURCE: Regen BioPharma, Inc.
Bio-Matrix Scientific Group’s Regen BioPharma Submits Response to FDA Questions Regarding HemaXellerate Clinical Program
February 05, 2013 10:35 ET | SOURCE: Regen BioPharma, Inc.
Regen BioPharma Files Investigational New Drug (IND) Application With FDA on HemaXellerate I™ Stem Cell Drug for Aplastic Anemia
January 24, 2013 08:30 | SOURCE: Regen BioPharma, Inc.
Regen BioPharma Peer-Reviewed Publication Provides Preclinical Support for HemaXellerate™ Bone Marrow Failure Product
November 19, 2012 08:30 ET | SOURCE: Regen BioPharma, Inc.
Bio-Matrix’ Regen BioPharma Initiates Pre-Clinical Study in Support of HemaXellerate™ Cell Therapy
October 29, 2012 10:30 ET | SOURCE: Regen BioPharma, Inc.
June 26, 2012 08:30 ET | SOURCE: Regen BioPharma, Inc.
Bio-Matrix Scientific Group, Inc. Recruits Senior Scientist for Its Regen BioPharma Subsidiary
June 26, 2012 08:30 ET | SOURCE: Regen BioPharma, Inc.
Bio-Matrix Scientific Group, Inc. Recruits Senior Scientist for Its Regen BioPharma Subsidiary
June 15, 2012 14:32 ET | SOURCE: Regen BioPharma, Inc.
Bio-Matrix Scientific Group Announces David Audley, the Founder of International Cellular Medicine Society, Has Joined the Advisory Board of Its Regen BioPharma Subsidiary
June 07, 2012 08:30 ET | SOURCE: Regen BioPharma, Inc.
Bio-Matrix Scientific Group’s Regen BioPharma Subsidiary Executes Option Agreement to License Stem Cell Intellectual Property